Latest Breaking News On - Kimia therapeutics - Page 1 : comparemela.com

Kimia Therapeutics Raises $55 Million Series A

Kimia Therapeutics Raises $55 Million Series A
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesStigk hansenTim kutzkeyJack sadowskyKimia therapeuticskimiaRay fuciniColumn groupKimia therapeutics incCarmot therapeutics incKimia therapeuticsHorizons venturesCarmot therapeuticsChemotype evolutionActive learningAutomated synthesisManaging partner

Roche joins race for obesity drugs with $2 7 billion

Roche joins race for obesity drugs with $2 7 billion
thefrontierpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thefrontierpost.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesThomas schineckerRoche grahamTeresa grahamLilly mounjaroEli lillyZuercher kantonalbankStig hansenNovo nordiskCarmot therapeuticsKimia therapeutics

Roche Joins Race for Obesity Drugs With $2 7 Billion Carmot Deal

Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly.

Stig hansenThomas schineckerSharon singletonRoche grahamEli lillyTeresa grahamZuercher kantonalbankLudwig burgerLilly mounjaroNoel illienNovo nordiskCarmot therapeuticsKimia therapeuticsFrankfurt additionalRachel moreLouise heavens

Roche joins race for obesity drugs with $2 7bln Carmot deal

Roche joins race for obesity drugs with $2 7bln Carmot deal
zawya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zawya.com Daily Mail and Mail on Sunday newspapers.

Thomas schineckerSharon singletonNoel illienLudwig burgerStig hansenZuercher kantonalbankEli lillyLilly mounjaroNovo nordiskCarmot therapeuticsKimia therapeuticsFrankfurt additionalRachel moreLouise heavens

Roche to buy obesity drug maker Carmot for $2 7 billion

For the Swiss drugmaker, deal marks a return to a GLP-1 field that it abandoned in 2018

Thomas schineckerStig hansenLilly mounjaroRoche grahamZuercher kantonalbankEli lillyTeresa grahamNovo nordiskImage creditCarmot therapeuticsKimia therapeutics